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Can law improve prevention and treatment of cancer?   
Symposium Introduction 
 
On 19 September 2011, the United Nations High Level Summit on Non-Communicable 
Diseases (NCDs) adopted an historic declaration.  The declaration calls for a multi-pronged 
campaign by governments, industry, and civil society to develop plans by 2013 to curb the 
risk factors for the four leading groups of NCDs – cardiovascular diseases, cancers, chronic 
respiratory diseases, and diabetes.1 
In 2008, NCDs accounted for 36 million deaths (63% of the global total), 80% of which 
occurred in low- and middle-income countries.2 The World Health Organisation (WHO) 
points out that with the exception of sub-Saharan Africa, NCD mortality “exceeds that of 
communicable, maternal, perinatal and nutritional conditions combined”.2,p9   
Belatedly, NCDs have been recognized as a major obstacle to development.  They entrench 
poverty and absorb scarce resources through treatment costs and lost productivity due to 
illness and premature death.3 The economic problem is compounded in low-income settings 
by the fact that household expenditure on NCD-inducing products, such as tobacco and 
alcoholic beverages, diverts household income away from much-needed goods such as food 
and education.4 NCDs represent not only a significant threat to global economic growth,5 
but also signal the need to revise the working model for global development priorities, 
hitherto encapsulated in the Millennium Development Goals.6 
The leading NCDs share preventable behavioural risk factors—chiefly, tobacco use, harmful 
use of alcohol, lack of physical activity, excess energy intake, and an unhealthy diet, which 
contribute, in turn, to elevated blood pressure, raised blood glucose, high cholesterol, and 
overweight and obesity. The leading NCDs share another similarity: progress is unlikely to 
come from self-regarding decisions taken by individuals alone, but will depend on 
comprehensive, national programs encompassing screening and early detection, policies for 
prevention, and the effective provision of health care services, including palliative care.2 
The UN NCD Declaration urges the adoption of national polices ranging from price and tax 
increases to curb smoking to restrictions on the extensive marketing to children of foods 
and beverages that are high in saturated fats, trans-fatty acids, sugars, or salt. The 
Declaration similarly proposes measures to reduce the harmful consumption of alcohol, 
promote overall healthy diets, and increase physical activity. 
The two-day NCD meeting at the General Assembly in New York was only the second high-
level summit in United Nation’s history. The first summit, on AIDS, changed the world. Could 
the NCD Summit come even close to achieving the same impact? This seems unlikely. 
Although the Declaration may become an historic turning point in global health, and may 
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eventually spark some re-calibration of effort and resources from infectious to chronic non-
communicable diseases, civil society expressed deep concerns with the Declaration’s 
wording.  Most controversial was the lack of urgency, specific targets and benchmarks, as 
well as the failure to include strategies to overcome barriers to access to essential 
medicines, particularly those posed by WTO and bilateral intellectual property agreements. 
The political declaration refers to the need for affordable, safe and effective medicines, and 
calls attention to flexibilities under the WTO trade-related aspects of intellectual property 
rights (TRIPS) agreement.7 However, it also studiously avoids any direct reference to NCDs 
as an “epidemic”, signalling the expectation that low- and middle-income countries would 
be required to negotiate access to medications for NCDs on ordinary commercial terms, 
rather than opening the way for manufacture and supply of medications without the 
permission of the patent holder, on grounds of public health emergency.8 
 
A Focus on Cancer Prevention and Treatment 
Taking cancer as its focus, this symposium explores the possibilities for using law and 
regulation – both internationally and at the national level – as the policy instrument for 
preventing and improving the treatment of NCDs.  There is an urgent need for more legal 
scholarship, and action, on cancer and other leading NCDs, together with greater dialogue 
between lawyers, public health practitioners and policy-makers about priorities for law 
reform, and feasible legal strategies for reducing the prevalence of leading risk factors.9 
Global cancer incidence is high and rising. In 2008 there were nearly 13 million new cancer 
cases.  By 2030, it is projected that there will be over 21 million new cases annually, with 
two thirds of these occurring in low- and middle-income countries.2  Hitherto, tobacco 
control has been the dominant focus of  public health scholars interested in cancer 
prevention; only recently has attention broadened to acknowledge the importance of other 
risk factors, including obesity10 and the harmful use of alcohol. An integrated account of 
law’s contribution to cancer prevention and treatment needs to take account of the wide 
range of modifiable determinants that have a legal dimension.  These include measures such 
as HPV and HBV vaccination, sunbed regulation, and controls on exposure to environmental 
risk factors, such as asbestos and radiation.  Population cancer screening programs – 
including mammographic, cervical and colorectal screening – as well as cancer surveillance, 
reporting procedures and registries, are all important components of a comprehensive 
approach, and inevitably have a legal underpinning. 
 
The World Cancer Declaration and UICC’s leadership 
This symposium is one of the outcomes of an international conference convened jointly by 
the Union for International Cancer Control (UICC) and the Sydney Law School on 10-11 June 
2010. UICC also hosted a session on legal approaches to cancer prevention and treatment at 
the World Cancer Congress held in Shenzhen, China, in August 2010.  Both conferences 
were part of a process, which this symposium continues, of exploring how law could serve 
as a resource for governments and other stakeholders to achieve the targets and implement 
the priority actions set out in the World Cancer Declaration, developed by the UICC and 
endorsed by the World Cancer Congress in 2008.11  More generally, as NCDs become the 
leading cause of disease burden in high-, middle- and, increasingly, low-income countries, 
we want to signal the importance of scholarship in this area and to nudge the vocabulary of 
public health law in a new direction: so that it becomes meaningful to discuss legal and 
regulatory responses to cancer, heart disease and diabetes in a more comprehensive and 
coherent way. 
One reason why there is a critical need for public health lawyers to engage with the 
challenge of cancer and NCDs is because successful implementation of many of the priority 
interventions for these diseases depends on legal and regulatory actions by 
governments.2,9,12  Table 1 sets out the population-wide interventions for cancer and NCD 
prevention, as identified in the World Health Organisation’s Global status report on 
NCDs,2,pp47-60 that are most likely to require legal and regulatory measures.  It also identifies 
those strategies that WHO has identified as most cost-effective (“best buys”), and locates 
each strategy within the WHO Framework Convention on Tobacco Control (2005) (FCTC),13 
the WHO Global Strategy to Reduce the Harmful Use of Alcohol (2010),14 and the WHO 
Global Strategy on Diet, Physical Activity and Health (2004).15 
The capacity of national and sub-national governments to implement these priority 
interventions through legislative and administrative actions will be affected by the 
constitutional structure of each country, including fundamental constitutional constraints 
on legislative power, and the division of legislative powers between tiers of government.  
Even in countries with a tradition of activism in tobacco control, some priorities remain 
breathtakingly ambitious.  For example, despite the global impact of alcohol misuse,16 
achieving restrictions on the sponsorship of sporting and cultural events by alcohol 
companies will require sustained efforts by public health and community groups – possibly 
for many years.  As was the case with tobacco control, a coherent, comprehensive response 
to risk factors for cancer and NCDs, which includes a basket of legal and regulatory 
interventions, is likely to develop incrementally.  Advocacy by public health practitioners will 
be critical to this process.  
In this editorial, we set out some of the most significant obstacles that stand in the way of a 
more effective use of law for the prevention and control of NCDs, particularly cancer, and 
briefly identify some of the strategies that law can deploy. 
 
Unhealthy choices and unhealthy environments 
Of the many challenges that regulatory responses to risk factors for cancer and NCDs raise, 
two stand out.  The first is the importance of unseating the popular view that, since risk 
factors like smoking, drinking to excess, eating a poor diet and living a sedentary lifestyle 
involve personal lifestyle choices, prevention is largely a matter of personal responsibility.  
The role of government, on this view, is limited to providing information and promoting a 
healthier lifestyle through mass media campaigns. 
In well-quoted comments made in 2006, former UK Prime Minister Tony Blair said: 
Our public health problems are not, strictly speaking, public health questions at all. 
They are questions of individual lifestyle – obesity, smoking, alcohol abuse, diabetes, 
sexually transmitted disease. These are not epidemics in the epidemiological sense. 
They are the result of millions of individual decisions, at millions of points in time.17 
Framing cancer prevention purely in terms of “millions of individual decisions” fails to 
recognize that individuals, and their lifestyle preferences, do not exist in a vacuum. Choices 
are patterned and moulded by the physical environment, economic circumstances, and 
social relationships.18  Ignoring this makes for a disarmingly simple political philosophy that 
appeals to the way in which consumers value choice and control over their own lives.  What 
escapes scrutiny, however, is the way in which corporate choices influence risks and 
behaviours across entire populations.  
Freudenberg and Galea point out that: 
No consumer ever entered a restaurant demanding a portion of trans fats.  Rather, 
food companies constrain consumer options through decisions made primarily to 
increase profits.  By exposing corporations as the real “nannies” who persuade 
children to eat to obesity…or patients to solve their social problems with a new drug, 
health professionals can reframe the discussion about who can be trusted to look 
after the public’s health.19 
While personal responsibility and self-control are powerful change strategies for individuals 
who wish to minimise health risks for cancer and NCDs, there is little evidence that 
delegating responsibility to the individual will be an effective prevention strategy at the 
population level.20-21 
Road safety presents a useful analogy.  Until relatively recently, fatigue, speed and driver 
error were widely seen as the major culprits in motor vehicle accidents and the human 
carnage crashes cause.  These human factors have long been, and remain, important causes.  
But the impressive declines in road fatalities seen in many developed countries through the 
latter part of the twentieth century were due less to changes in driver behaviour than to 
radical redesign of vehicles and motorways to minimise the risks and consequences of 
accidents.22    
As Table 1 illustrates, regulatory interventions that focus on improving the physical, 
economic and policy environment that lies outside of the individual have the advantage that 
they can support and empower both individuals and populations to live healthier lives.23  By 
focusing on the environment, rather than by directly targeting individuals and their 
behaviours, governments can avoid coercion and discrimination, and minimize direct 
interferences with personal autonomy. 
On the other hand, placing the emphasis on healthier environments creates new challenges.  
The behavioural health risks in our lives are linked with commercial products and business 
interests in many complex ways.24  For example, motor cars, television and computer games 
play a large role in keeping us physically inactive.  Socially constructed ideals around body 
image encourage the use of tanning solariums25 and undermine attempts to quit smoking 
for fear of weight gain.26  The advertising of energy-dense snacks and sugar-sweetened 
beverages contributes to weight gain,27-28 but so too might production and export subsidies 
for meat, sugar and oils, which are poorly aligned with nutritional guidelines but  influence 
what goes into commodity foods.29-32  The question of whether alcohol labelling, food 
advertising, or some other aspect of business practice, deserves the attention of regulators 
depends on its contribution to the overall burden of disease.  Yet this is not a straight-
forward issue for diseases and conditions that, like cancer, obesity or diabetes, have 
multiple environmental determinants.  Just as importantly, regulation becomes a highly 
political issue for governments: which business-related determinants of disease should be 
selected out for regulatory control? 
 
Terms of engagement: tobacco, alcohol and food 
It is precisely because the priority interventions in Table 1 target the external environment, 
rather than individuals themselves, that they create the potential for conflict with the 
tobacco, alcohol, food, and retail industries.  Again, the contemporary history of automobile 
safety is illuminating.  Moves by Ralph Nader and other activists in the 1960s and 1970s to 
turn the spotlight from drivers to environmental determinants33 created instant conflict 
with the automobile industry.  While confrontational approaches can yield breakthroughs in 
certain circumstances, it is almost certainly too blunt a strategy to fit all of the influences 
and actors in the NCD sphere.  The second challenge for law reformers, therefore, is to 
determine the terms of engagement with these industries, including the prospects for 
partnerships and the merits of co-regulation. 
There are significant differences between the tobacco, alcohol and food industries, despite 
the fact that all three benefit economically from the patterns of overconsumption that 
contribute to cancer and NCDs.  The tobacco industry has a history of attempting to subvert 
public health efforts34 and to engineer tobacco products for taste and addictiveness.35  
Guidelines made under the Framework Convention highlight the “fundamental and 
irreconcilable conflict between the tobacco industry’s interests and public health policy 
interests”; they also point to the benefits of limiting interactions with the tobacco industry 
in order to protect the formulation and implementation of public health policies from 
industry influence to the “greatest extent possible”.36 There is near consensus among public 
health experts that substantial regulation of the tobacco industry is a good thing, and that 
such regulation should focus both on limiting uptake of smoking, especially among children 
and youth, and helping existing smokers to quit.  Over time, this strategy should continue 
the gradual contraction of the tobacco economy.  Where these efforts flag, or are stymied, 
direct confrontation with the industry may well be appropriate. 
With respect to alcohol, there is evidence that modest intake may reduce the risk of 
cardiovascular disease,37 although alcohol is also a neglected carcinogen, and cancer risk 
rises with level of consumption.16,38-39 As with tobacco, governments have an interest in 
supply-side regulation, because the sale of untaxed and informally-produced alcohol at 
lower prices both reduces government revenues and undermines public health goals.  
Reducing the burden of cancer requires substantial reductions in levels of alcohol 
consumption at the population level.  However, selling moderation – and the forms of 
regulation most likely to result in more moderate levels of drinking – is extremely difficult.  
The alcohol industry is highly concentrated, innovative and global in scope.40  Although 
internal alcohol industry documents are generally unavailable, available sources illustrate a 
range of strategies to counter the threat of regulation.  These include contesting the 
relationship between advertising and levels of consumption; support for voluntary, industry-
controlled educational initiatives; and focusing on individual rather than corporate 
responsibility.41-42 
Although food is necessary for life, the WHO points out that reducing the burden of NCDs, 
including cancer, will require an overall reduction in calories, as well as reduced levels of 
consumption of salt, sugar and saturated fats at the population level.2,15 Factors that have 
contributed to weight gain and dietary imbalance include the reduced cost of food over 
time, particularly energy-dense carbohydrates; real income growth (leading to greater 
consumption of meat products and thus saturated fat); and the global marketing of pre-
prepared meals and snack foods.  Competition within the food sector leads to larger portion 
sizes and marketing that appeals to inbuilt preferences for sweet, fatty, salty, energy-dense 
foods.43-46 
Yach and colleagues have argued that the solutions to obesity and diet-related disease 
partly depend on the “innovation and efficiency of the food industry”.47  They point to the 
need for public-private partnerships with government, researchers and community groups, 
combined with greater understanding of the constraints posed by food science, consumer 
behaviour, commodity prices and supply chains.48 
On the one hand, the trust and goodwill required to make partnerships and voluntary 
regulation work may be difficult to achieve if the food industry – like the tobacco industry – 
is framed as a “vector of disease”, and diet-related diseases as an “industrial epidemic” 
arising from the commercialization of unhealthy food.49 On the other hand, recent evidence 
suggests that without the spectre of regulation, the food industry has little commitment to 
its own voluntary pledges,50 and little interest in assisting consumers to make healthier food 
choices through, for example, evidence-based, front-of-pack traffic light labeling.51-52   
 
Symposium on legal approaches to cancer prevention and treatment 
There is no single blueprint for the legal interventions that could most effectively reduce 
cancer risks across the population.  Although we believe that legal strategies have a role to 
play in reducing tobacco, alcohol and diet-related risks, there will be much to learn from 
sharing experiences between jurisdictions in the years ahead, and much to debate in the 
meantime. 
Legislation is not a new phenomenon for cancer prevention. In the United States, for 
example, President Nixon’s “war on cancer” led to the National Cancer Act of 1971 (P.L. 92-
218), which strengthened the role of the National Cancer Institute.  More recently, in 
Australia, the Cancer Australia Act 2006 was introduced to provide national leadership in 
cancer control.  As these examples illustrate, public health law is not only a tool for 
regulating business and the physical and economic environment; it is also a tool for re-
shaping the capacity of government, including local governments, to implement effective 
policies. 
Table 2 sets out some of the principal ways in which law can help to reduce behavioural risk 
factors for cancer and other NCDs.  It draws on Lawrence Gostin’s model of law as a tool for 
public health.53 At the national level, familiar forms of regulation include economic 
interventions (such as taxes on tobacco and alcoholic beverages, or conditional grants from 
the federal government to state or local governments), as well as interventions in the 
informational environment (surveillance and reporting of risk factors, improved labelling 
and health warnings, and advertising controls).  Global health governance, including 
international laws, global strategies and guidelines, also play a vital role in cancer control.  
As Table 1 illustrates, a consensus is emerging about the most promising legal measures for 
helping to reduce risks for cancer and other NCDs at the population level.2,12,54-55 These law 
reform priorities draw directly from the standards set out in the FCTC and from global 
strategies. 
Global governance, as well as national-level regulation both feature in the contributions to 
this symposium. Robert Beaglehole, Ruth Bonita and Roger Magnusson set out the global 
context for this symposium by reviewing the global burden of cancer and the priority 
interventions for the leading risk factors.  Around one third of cancer cases (>2.6 million per 
year) are preventable with existing knowledge and interventions.  As the authors illustrate, 
in addition to tobacco and alcohol control, a comprehensive response to cancer requires 
interventions to reduce obesity and promote physical activity, wider and more effective 
delivery of vaccinations for infectious causes of cancer, and renewed attention to 
environmental regulation, including radiation exposure, chemical safety, and sunbed 
regulation. 
The growing focus on NCDs within the World Health Organisation, UN agencies and the 
World Bank has not been matched by sufficient consideration of the role of international 
economic law. Tania Voon and Andrew Mitchell examine the implications of World Trade 
Organisation (WTO) law for domestic regulatory efforts targeting common risk factors for 
NCDs: tobacco use, harmful use of alcohol, and poor diet. Although WTO law is often raised 
by tobacco companies and tobacco control advocates alike as a barrier to sensible health 
regulation, the authors argue that WTO agreements provide significant flexibilities for WTO 
member countries that wish to implement measures to protect public health, and can even 
be used as a tool to promote health policy.  Voon and Mitchell conclude that international 
trade regulation should not be seen as an insurmountable obstacle to progressive regulation 
against cancer and other NCDs, or their risk factors. 
The development, manufacture, trade and distribution of medicines all take place within a 
web of international legal obligations that states have accepted under a range of 
multilateral and bilateral agreements. Jonathan Liberman examines two areas of 
international law that are relevant to cancer treatment: the international drug control 
system, which regulates opioid analgesics, and the WTO’s Trade-related aspects of 
intellectual property rights (TRIPS) agreement.7  Liberman outlines recent developments in 
relation to both, including the activities of the Vienna-based agencies that collectively 
oversee the implementation of the Single Convention on Narcotic Drugs, and the 
negotiations leading up to the recent United Nations General Assembly Political Declaration 
on Noncommunicable Diseases.1 While underlining the importance of law, Liberman points 
out that battles over law should not distract from the importance of other efforts to 
enhance access to medicines, as part of the process of strengthening national health 
systems. 
Tobacco use remains the single most preventable cause of death globally. The Framework 
Convention on Tobacco Control (FCTC),13 which now has more than 170 parties and 
continues to influence national laws and policies, is the most powerful international legal 
tool currently in existence to reduce the global burden of NCDs.  Katherine DeLand and 
Gemma Lien discuss how tobacco control gained traction as a topic for global governance, 
and review key successes and challenges in the six years since the FCTC came into force, 
including those relating to protocols negotiated under the FCTC.  As the focus of global 
prevention efforts moves beyond tobacco, and as proposals are advanced for new 
international agreements on alcohol, obesity, and global health,56 DeLand and Lien consider 
whether the FCTC is a regulatory model that could be successfully deployed elsewhere. 
Having considered some of the leading legal and regulatory issues that arise at the global 
level, the papers in the symposium then turn to domestic laws and policies. In a longer 
paper, Roger Magnusson considers the case for using law to respond to cancer risks, and 
offers a framework for understanding how law could contribute to cancer prevention.  He 
illustrates the application of this framework by taking Australia as a case study, evaluating 
priority areas for law reform at federal and state level, and placing these in the context of 
existing laws and policies.  The framework outlined, as well as the law reform priorities and 
regulatory issues discussed, will be relevant to other countries with a substantial cancer 
burden. 
While law can be a positive force for improving the treatment and prevention of cancer, it 
can also act as a barrier, as Ian Olver argues.  Olver identifies four areas where he believes 
Australian law and regulatory processes act as barriers to more effective cancer treatment. 
Privacy laws and concerns currently limit the electronic collection, linkage and sharing of 
patient data in ways that undermine effective patient treatment.  Drug regulation processes 
also need updating, to ensure that regulatory approvals granted for targeted cancer 
treatments extend to the tests for identification of the target, as well as the drug itself. 
Olver argues that gene patenting laws have allowed patents for discoveries that add little in 
the way of innovation to clinical science and medicine, and that this threatens the 
widespread availability of emerging genetic tests and treatments for cancer.  Finally, Olver 
explains how the burden of cancer and NCDs will require changes in the design of the health 
workforce, while maintaining safety and quality standards. 
Turning to alcohol, Sondra Davoren points out that the policy and prevention literature 
focuses predominantly on the impact of alcohol policies over the short term. However, 
evidence is growing about the effect of interventions on long-term, alcohol-related chronic 
disease, including cancers. Davoren argues that experience with tobacco control supports 
interventions to increase the price of alcohol and to restrict its availability, in order to 
reduce consumption and to achieve longer-term health gains. Political inertia and the 
negative impact of the alcohol industry on the development of alcohol policy, she argues, 
are hampering legal interventions that could potentially save many lives.  As the burden of 
alcohol-related cancers becomes more apparent, initiatives to introduce effective alcohol 
policies should be introduced sooner rather than later.  
The environments where people live, learn, work, and play on a daily basis have a profound 
influence on health, by either promoting or discouraging behaviour associated with cancer 
and other chronic diseases. Advising individuals to increase their physical activity, avoid 
tobacco, and eat a diet rich in fruits and vegetables might motivate some people to make 
healthier choices, but their ability to do so hinges on access to an environment where 
healthy choices are readily available – where people can walk safely through neighborhood 
streets, breathe smoke-free air in their homes, and buy fresh produce at local stores. Marice 
Ashe, Samantha Graff and Carrie Spector point out that in the United States, local 
governments have tremendous latitude to regulate the physical environments that 
residents experience every day, through policies addressing physical activity, access to 
healthy foods, and the prevalence of tobacco products. Their paper looks at innovative ways 
to improve public health through laws and policies targeted specifically to local places, 
including schools, workplaces, recreational areas, food stores, and restaurants. 
Legislative approaches to obesity prevention and healthier eating remain a highly contested 
area, even among public health advocates.  Sarah Mackay outlines the roles that law could 
play, pointing out how the tendency to assess regulatory interventions through the frame of 
“personal responsibility” remains a barrier to political acceptance of legislative approaches.  
Mackay focuses in particular on the disclosure of nutritional information about food and 
beverage products, with the goal of better informing consumer choices and facilitating the 
exercise of personal responsibilities by individuals.  She argues that political acceptance of 
law reforms in this area appears to be growing in Australia, and could provide a starting 
point for incremental progress in responding to diet-related risk factors for cancer and 
NCDs. 
Finally, Cameron Stewart’s paper deals with the reality of dying from cancer, and the law’s 
management of the dying process.  As cancer and other NCDs continue to be major causes 
of death, questions arise as to how law should regulate limitations upon treatment, and 
pain control for dying patients. Given the increasingly large proportion of people who will 
die in institutional care, the law’s regulation of death management has become a “whole of 
population” issue that will affect the lives of many people. Stewart believes that law has a 
vital role in delivering the best possible end-of-life care, and sets out five desiderata that law 
should address.  He also argues that poorly drafted laws can cause harm to patients, a 
process he refers to as nomoigenesis.  Although Stewart illustrates his thesis about the 
disiderata and nomoigenesis by referring to Australian legislation, his arguments have 
broader application across a range of common law jurisdictions. 
Encouraging governments to regulate for the sake of the health of populations is not an 
activity reserved for public health lawyers.  Advocacy by public health professionals with a 
stake in improving the prevention and treatment of NCDs is crucial, but requires a measure 
of legal literacy and an understanding of the legal issues that cancer raises at global and 
national levels.  This symposium issue of the journal was edited by Lawrence Gostin, 
Jonathan Liberman, Roger Magnusson, and David Studdert.  We hope that this collection of 
papers will help to fulfil this role, and thank each of the authors for their contributions. 
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Table 1 
Population-wide interventions for preventing cancer and NCDs that are likely to require 
legal and regulatory actions by governments for effective implementation13-16 
Governance 
reform 
 Institutional and governance reform to enable development 
of a comprehensive and multi-sectoral approach to policy 
development for diet, nutrition and physical activity, with 
input from key sectors (agriculture, transport, education, 
environmental and urban planning, sport, youth, industry, 
finance, and media and communications). City and local 
governments should have a legal mandate to play a leading 
role (WHO Global Strategy on Diet, paras 38-44) 
 
Economic 
strategies 
 Imposing higher excise taxes on tobacco to reduce demand 
(FCTC Article 6) 
 Increasing excise taxes on alcoholic beverages (WHO Global 
Strategy on Alcohol, paras. 32-34) 
 Penalties for smuggled and counterfeit tobacco and for 
smuggled and informal alcohol, with appropriate investments 
in monitoring and enforcement (FCTC  Article 15; WHO 
Global Strategy on Alcohol paras. 37-39) 
 Affordable treatment for tobacco dependence: supporting 
interventions for smoking cessation in primary care; 
affordable pharmacological therapies (FCTC Article 14) 
 Consider production incentives or reduced taxation on 
healthier foods; higher taxation for foods to be consumed in 
lower quantities (WHO Global Status Report, p 53) 
BEST BUY 
 
BEST BUY 
 
 
 
GOOD BUY 
Environmental 
controls 
 Protection from environmental tobacco smoke: smoking bans 
in public places, including workplaces, public transport, bars 
and restaurants (FCTC Article 8) 
BEST BUY 
 
Restricting 
advertising 
 Implementing and enforcing bans on tobacco advertising, 
promotion and sponsorship (FCTC Article 13) 
 Implementing and enforcing restrictions on alcohol 
advertising and promotion through the media, in community 
settings and retail settings; restrictions on alcohol 
sponsorship of sporting and cultural events (WHO Global 
Strategy on Alcohol, paras. 29-31) 
 Labelling controls, including health warnings on tobacco and 
alcohol products (FCTC Article 11; WHO Global Strategy on 
Alcohol para 36) 
 Constraints on advertising and promotion of foods and 
beverages high in salt, sugar and saturated fat to children 
(WHO Global Status Report, p 53; WHO. Set of 
recommendations on marketing of foods and non-alcoholic 
beverages to children WHA 64.14, adopted May 2010). 
BEST BUY 
 
BEST BUY 
 
Regulating  Prohibiting sales of tobacco and alcohol to and by children,  
retail sales with proof of age requirements, and appropriate investments 
in monitoring and enforcement (FCTC Article 16; WHO Global 
Strategy on Alcohol, paras. 27-28) 
 Restricting the availability of alcoholic beverages, including: 
minimum purchasing age; restrictions on location and density 
of retail outlets, and on hours of permitted sale through 
licensing conditions (WHO Global Strategy on Alcohol, paras. 
27-28) 
 Health warnings at point of sale (see FCTC Article 12; see 
WHO Global Strategy on Alcohol paras. 19,36) 
Product 
reformulation 
 Encouraging food reformulation through public reporting of 
food manufacturers’ commitments to progressive reductions 
in salt levels in food (WHO Global Strategy on Diet, para 41) 
 Requiring food manufacturers to replace trans fats with 
polyunsaturated fats (WHO Global Strategy on Diet, para 41; 
WHO Global Status Report, p 52) 
 Targets for replacing saturated with unsaturated fats in 
products (WHO Global Status Report, p 53) 
BEST BUY 
 
BEST BUY 
 
Direct 
constraints on 
the behaviour 
of individuals 
 Drink-driving counter-measures, including random breath 
testing, a maximum 0.5 g/l blood alcohol concentration (BAC) 
limits for adult drivers, with a reduced or zero limit for young 
drivers (WHO Global Strategy on Alcohol, paras. 24-26; NCDs 
Global Status Report p 51) 
 Smoking restrictions (above) 
BEST BUY 
 
Other strategies  HBV vaccination 
 Policies to improve health literacy and a healthy diet at 
school (WHO Global Strategy on Diet, para 43) 
BEST BUY 
 
Supporting 
breastfeeding 
 Legislation to protect women’s right to breast-feed, without 
harassment or discrimination 
 
 
  
Table 2 
Ways in which legal and regulatory interventions can reduce the prevalence of behavioural 
risk factors for cancer and other NCDs 
 Improving health infrastructure and governance: This includes creating agencies with a 
clear mandate to follow the evidence, to enforce legal requirements and to promote 
healthy lifestyles. It also includes cross-sectoral initiatives to encourage healthy policy-
making in settings and government sectors beyond health; for example, transport, 
agriculture, sport and recreation, taxation and finance, local government, the workplace, 
or schools. 
 Improving the informational environment: For example, by mandating the provision of 
information to consumers to encourage healthier decisions (eg food labelling, warnings 
on alcohol and tobacco products), and by banning or restricting the advertising of 
tobacco, alcohol and energy-dense, nutrient poor foods, especially to children. 
 Economic strategies: Governments can encourage healthier behaviours by altering the 
costs of behaviour; for example, by raising taxes on tobacco products and alcoholic 
beverages.  As an alternative to taxing, governments can spend; for example, through 
food programs to improve nutrition for vulnerable and low-income groups. 
Governments can also create incentives for private-sector initiatives; for example, by 
giving tax relief for employers who invest in health promotion and risk factor prevention 
in the workplace. 
 Improving the physical and built environment: Governments can use law to create 
healthier physical environments, through measures such as smoke-free laws, restrictions 
on the retail licensing of alcohol and tobacco, and by integrating health impact 
assessment within planning and development approval processes. National and/or 
regional governments can create a mandate for local governments to develop strategies 
to reduce risk factors for NCDs within the local environment, with targets and incentives 
for meeting performance. 
 Regulating the manufacturing and retail sectors: While voluntary and self-regulatory 
standards may be appropriate in some areas, governments can impose technical legal 
requirements as well as performance standards upon businesses, employers, and 
providers of goods and services.  These cover a wide range, from bans on trans fats in 
restaurant foods, to technical regulations about how obesity, smoking status and other 
risk factors can affect premiums and health insurance coverage. 
 Social policies: Governments can use law as part of wider strategies to reduce socio-
economic disparities in health and to ensure equality of opportunity in accessing the 
conditions that are necessary to live a healthy life.  Examples include direct financial 
assistance to vulnerable families, financing and incentives to attract supermarkets and 
fresh food outlets to underserved areas, as well as New York’s microloans and licensing 
scheme to establish “green carts” selling fresh produce on city streets. 
 
